RCON [Recon Technology] S-1: RECON TECHNOLOGY, LTD Investing in these units involves

[RECON TECHNOLOGY, LTD Investing in these units involves significant risks. See “Risk Factors” beginning on page 8 of this prospectus. Per Unit Total Public offering price $ $ Underwriting discounts and commissions $ $ Proceeds to us, before expenses] [ANSEN ARNETT AXWELL P C H A Professional Corporation Registered with the Public Company CERTIFIED PUBLIC ACCOUNTANTS Accounting Oversight Board 5 Triad Center, Suite 750 Salt Lake City, UT 84180-1128 Phone: (801) 532-2200 Fax: (801) 532-7944 www.hbmcpas.com CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors Recon Technology, Ltd. As an independent registered public accounting firm, we]

By | 2016-03-13T08:18:59+00:00 May 5th, 2010|Categories: Chinese Stocks, RCON, Webplus ver|Tags: , , , , , |0 Comments

GSI [GENERAL STEEL] PRER14C: (Original Filing)

[] [May 5, 2010 Page 2 Summary of Corporate Actions, page 7 Comment (2) Response (2) In the Information Statement, we have revised the subsection entitled “General” in the section entitled “Summary of Corporate Actions” to disclose the provisions of Section 312 giving rise to the shareholder approvals.]

GSI [GENERAL STEEL] PRER14C:

[] [May 5, 2010 Page 2 Summary of Corporate Actions, page 7 Comment (2) Response (2) In the Information Statement, we have revised the subsection entitled “General” in the section entitled “Summary of Corporate Actions” to disclose the provisions of Section 312 giving rise to the shareholder approvals.]

NCTY [The9] SC 13G/A: (Original Filing)

[JOINT FILING AGREEMENT ELECTRONIC ARTS INC. TEPHEN ENÉ Stephen G. Bené Senior Vice President, General Counsel and Corporate Secretary EA INTERNATIONAL (STUDIO AND PUBLISHING) LTD. ARINDER AINI Varinder Saini Manager, International Publishing EX-99.A 2 dex99a.htm JOINT FILING AGREEMENT] [CUSIP No. 88337K104 13G Page 2 of 8 Pages 1. NAME OF REPORTING PERSON/I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Electronic Arts Inc. (“EA”) I.R.S. Identification No. 94-2838567 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) ¨ x (a)]

CXDC [China XD Plastics Co] 10-K/A: (Original Filing)

[EXPLANATORY NOTE —] [I, Jie Han, certify that: 1. I have reviewed this annual report on Form 10-K/A of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification of Principal Financial Officer I, Taylor Zhang, certify that: 1. I have reviewed this annual report on Form 10-K/A of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Taylor Zhang Principal Financial and Accounting Officer] [Response Staff Comment 3. http://pcaobs.org/Standards/QandA/QA_Adjustments.pdf Response The Company acknowledges that: · The Company is responsible for the adequacy and accuracy of the disclosure in the filing; · Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and ·]

By | 2016-03-25T18:39:02+00:00 May 5th, 2010|Categories: Chinese Stocks, CXDC, SEC Original|Tags: , , , , , |0 Comments

CXDC [China XD Plastics Co] 10-K/A: EXPLANATORY NOTE —

[EXPLANATORY NOTE —] [I, Jie Han, certify that: 1. I have reviewed this annual report on Form 10-K/A of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification of Principal Financial Officer I, Taylor Zhang, certify that: 1. I have reviewed this annual report on Form 10-K/A of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Taylor Zhang Principal Financial and Accounting Officer] [Response Staff Comment 3. http://pcaobs.org/Standards/QandA/QA_Adjustments.pdf Response The Company acknowledges that: · The Company is responsible for the adequacy and accuracy of the disclosure in the filing; · Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and ·]

By | 2016-03-25T18:39:50+00:00 May 5th, 2010|Categories: Chinese Stocks, CXDC, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] DEF 14C: (Original Filing)

[SCHEDULE 14C INFORMATION Check the appropriate box: [] Preliminary Information Statement [] [X] Definitive Information Statement CHINA PHARMAS, Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]

By | 2016-02-07T23:28:59+00:00 May 5th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] DEF 14C: SCHEDULE 14C INFORMATION Check the appropriate box: []

[SCHEDULE 14C INFORMATION Check the appropriate box: [] Preliminary Information Statement [] [X] Definitive Information Statement CHINA PHARMAS, Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]

By | 2016-02-07T23:29:33+00:00 May 5th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar